+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Forecast 2024-2030- Product Image
Global CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Forecast 2024-2030- Product Image
Sale

Global CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924674
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The CRISPR Gene Editing Market size was estimated at USD 3.25 billion in 2023, USD 3.77 billion in 2024, and is expected to grow at a CAGR of 16.81% to reach USD 9.66 billion by 2030.

CRISPR gene editing, referred to as CRISPR-Cas9, is a revolutionary biochemical technology that enables geneticists and medical researchers to edit and modify parts of the genome by adding, removing, and altering parts of the DNA sequence. It is one of the simplest, most versatile, and precise methods of genetic manipulation. The rising prevalence of genetic disorders, along with the increasing demand for personalized medicine, is owing to the market growth. Additionally, significant investments in research and development by biotech and pharma sectors and governmental and regulatory support for gene editing applications play a vital role in fostering market development.

However, off-target effects, ethical concerns surrounding human germline editing, and the potential for unintended consequences in the environment are significant issues limiting the market growth. Furthermore, the advancement of precision agriculture through crop design and the enhancement of cellular and genetic research methods create lucrative opportunities for market growth.

Regional Insights

In the Americas, particularly the United States and Canada, there is a significant emphasis on the advancement of CRISPR technology due to the high prevalence of genetic disorders and chronic diseases. Consumer needs are focused on personalized medicine and the potential of CRISPR to provide novel treatments. The United States is at the forefront in terms of CRISPR patents, with notable research being conducted by biotech giants and prestigious academic institutions. European Union (EU) countries have a robust regulatory framework guiding biotechnology applications that impact both consumer needs and purchasing behavior.

The presence of stringent regulations, encouraging thorough, safe development on the one hand but potentially slowing innovation and adoption on the other. In the Middle East and Africa regions, CRISPR technology is still in the nascent stages of adoption. Due to varying levels of economic development and healthcare infrastructure, consumer needs and customer behavior differ significantly across these territories. The Asia Pacific region presents a diverse and rapidly evolving market for CRISPR gene editing. In China, CRISPR technology is receiving massive state and private investment, pushing forward substantial research and applications, especially in medicine and agriculture. Japan demonstrates a strong investment in the field, aligning its technological advancements with regulations sensitive to public concerns about genetic modification.

Market Trends by Segment

  • Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
  • End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

Synthego and SeQure Dx formed a strategic alliance to advance the development of CRISPR therapeutics. This collaboration equips developers with an all-encompassing off-target editing analytic service, leveraging SeQure Dx's distinguished ONE-seq assay technology and Synthego's robust suite of synthetic guide RNAs. The seamless integration of these offerings promises to streamline the therapeutic development cycle, enhancing safety and efficiency while satisfying stringent regulatory standards.

CRISPR QC Raises USD 10 Million in Series A Financing Round

CRISPR QC, a startup based in San Diego, concluded a Series A funding round with a significant USD 10 million investment. Specializing in assessing CRISPR/Cas9 gene-editing endeavors, CRISPR QC is pioneering the field with its innovative platform that utilizes the CRISPR-Chip, a high-precision biosensor designed to evaluate CRISPR activity accurately. This funding triumph comes from a seed funding round that garnered USD 1.6 million, reflecting growing confidence and interest in CRISPR QC's potential to transform gene editing quality control.

Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal

Tome Biosciences announced the acquisition of Replace Therapeutics in a strategic move, accelerating its footprint in the burgeoning gene editing sector. This acquisition underscores Tome's ambition to broaden its disease treatment portfolio and embodies the growing valuation of the gene editing market. Replace's contribution to Tome's suite with its ligase-mediated programmable genomic integration (L-PGI) complements Tome's existing large DNA edits, enhancing the company's capabilities in addressing various genetic conditions with high efficiency and specificity.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AstraZeneca PLC, Beam Therapeutics Inc., Bio-Rad Laboratories, Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Qiagen NV, Sherlock Biosciences, Inc., Thermo Fisher Scientific Inc., and ToolGen, Inc.

This research report offers invaluable insights into various crucial aspects of the CRISPR Gene Editing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
5.1.1.3. Adoption of CRISPR gene editing in space investigation
5.1.2. Restraints
5.1.2.1. High cost of CRISPR therapies
5.1.3. Opportunities
5.1.3.1. Advancements and improvements in CRISPR gene editing
5.1.3.2. Potential use of CRISPR gene editing in the agriculture sector
5.1.4. Challenges
5.1.4.1. Technical challenges and ethical concerns associated with CRISPR gene editing
5.2. Market Segmentation Analysis
5.2.1. Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
5.2.2. End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. CRISPR Gene Editing Market, by Offering
6.1. Introduction
6.2. Reagents & Consumables
6.3. Services
6.4. Software & Systems
7. CRISPR Gene Editing Market, by Technology
7.1. Introduction
7.2. Anti-CRISPR Proteins
7.3. CRISPR/Cas13
7.4. CRISPR/Cas9
7.5. CRISPR/Cpf1 (Cas12a)
8. CRISPR Gene Editing Market, by Application
8.1. Introduction
8.2. Diagnostics & Therapy Development
8.3. Genetic Engineering
9. CRISPR Gene Editing Market, by End-use
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Pharmaceutical & Biotechnology Companies
10. Americas CRISPR Gene Editing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific CRISPR Gene Editing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa CRISPR Gene Editing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
13.3.2. CRISPR QC Raises USD 10 Million in Series A Financing Round
13.3.3. Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CRISPR GENE EDITING MARKET DYNAMICS
FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 78. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 79. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 80. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 81. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 84. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 85. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 86. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 87. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 88. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 89. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 90. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 91. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 94. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 95. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 131. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 132. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 133. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 138. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 139. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 140. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 141. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 142. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 143. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 144. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 145. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 148. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 149. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 152. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 161. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 162. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 163. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 164. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 165. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 168. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 169. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 172. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 181. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 182. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 191. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 192. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 202. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 211. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 212. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 221. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 222. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 223. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 224. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 225. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 228. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 229. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 230. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 231. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 232. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 253. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 254. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 255. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 256. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 257. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 260. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 261. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 262. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 263. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 264. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 265. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 266. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 267. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 270. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 271. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 272. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 273. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 274. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 275. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 276. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 277. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 280. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 281. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 284. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 285. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 286. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 287. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 290. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 291. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 292. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 293. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 294. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 295. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 296. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 297. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 300. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 301. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 302. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 303. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 304. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 305. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 313. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 314. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 315. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 316. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 317. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 320. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 321. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 322. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 323. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 324. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 325. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 326. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 327. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 333. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 334. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 335. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 336. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 337. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 343. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 344. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 345. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 346. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 347. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD

Companies Mentioned

  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Beam Therapeutics Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Biosciences, Inc.
  • Cellectis S.A.
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • F. Hoffmann-La Roche AG
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd. by Revvity, Inc.
  • Inscripta, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Prime Medicine, Inc.
  • Qiagen NV
  • Sherlock Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.66 Billion
Compound Annual Growth Rate16.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service, By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service, By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 160 Pages
  • Global
From
Global Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Forecast 2024-2030 - Product Image

Global Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Forecast 2024-2030 - Product Image

Global CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN, TALEN), By Delivery Method (Ex-vivo, In-vivo), By Application, By Mode, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN, TALEN), By Delivery Method (Ex-vivo, In-vivo), By Application, By Mode, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Gene Editing Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Component, Technology, Application, End User, and Geography - Product Image

Gene Editing Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Component, Technology, Application, End User, and Geography

  • Report
  • 150 Pages
  • Global
From

About the CRISPR Gene Editing Market

The CRISPR Gene Editing market is a subset of the larger Genomics market. It is a rapidly growing field, driven by advances in gene editing technology and the potential for its applications in a variety of areas. CRISPR technology enables scientists to make precise changes to the genetic code of living organisms, allowing them to modify or delete genes, and even insert new ones. This technology has the potential to revolutionize the way we treat diseases, create new crops, and even modify the human genome. The CRISPR Gene Editing market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and Horizon Discovery. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.